HPE Private Cloud Enterprise will enhance scalability and operational performance for Lupin. BENGALURU, India, April 23, 2025--(BUSINESS WIRE)--Hewlett Packard Enterprise (NYSE: HPE) today ...

Directed by the Lupin III trilogy’s Takeshi Koike and penned by Lupin Part IV’s Yuya Takahashi, Lupin the IIIrd: The Movie is the animated equivalent of a meticulously planned heist ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for tolvaptan ...

Mumbai: Indian generics drug maker, Lupin wholly owned diagnostic arm Lupin Diagnostics Limited (LDL) has obtained NABL (National Accreditation Board for Testing and Calibration Laboratories ...

Shares of Lupin Ltd. edged 2.5 percent higher on Wednesday after the company announced the launch of Tolvaptan tablets in the US market, marking a key milestone in its US generics portfolio.

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.

Introduced in FY23, Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers ...

Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for Tolvaptan tablets of different strengths. It is the exclusive first-to-file for this product and consequently ...

Lupin gets US FDA approval for Tolvaptan tablets. Tolvaptan tablets to be produced at Nagpur facility. Market exclusivity granted for 180 days in the US. Lupin Limited on Thursday said it received ...

Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA), for drug-medical device ...

The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' overactive bladder drug, Myrbetriq, in the United States. According to the ...

The gradual upward movement suggests the beginning of a new bullish leg from current levels. Lupin has given a breakout from its symmetrical triangle chart pattern with a strong bullish candlestick.